LogoSFPNet4CGD, Gene Therapy for X-linked Chronic Granulomatous Disease (CGD), is a large-scale integrating project in Health Research of the European Commission 7th framework programme (FP7). The Net4CGD project is focused on the clinical development of a new orphan drug of gene therapy that can rapidly become a new treatment option for patients with the X-linked form of CGD. The Net4CGD consortium consists of 11 partners Institutions and is coordinated by Genethon, France.